Cancer and Rheumatoid Arthritis

Xerxes Pundole, Maria E. Suarez-Almazor

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Management of rheumatoid arthritis (RA) in patients with cancer is complex and requires a multidisciplinary approach. A few studies have examined the risk for recurrence in patients with RA receiving disease-modifying antirheumatic drugs, primarily tumor necrosis factor-α inhibitors. Although these agents seem to be safe in patients with a history of cancer and no evidence of disease, additional information is needed to determine their potential effects in patients with RA and active cancer. Patients with RA undergoing cancer therapy, including surgery, radiation, chemotherapy, and immunotherapy, need to be carefully monitored because they are at increased risk for adverse events.

Original languageEnglish (US)
Pages (from-to)445-462
Number of pages18
JournalRheumatic Disease Clinics of North America
Volume46
Issue number3
DOIs
StatePublished - Aug 2020

Keywords

  • Biologic therapy
  • Cancer
  • Disease-modifying antirheumatic drugs
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Cancer and Rheumatoid Arthritis'. Together they form a unique fingerprint.

Cite this